Cite

    Roberto Latagliata et al.. “Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.” Hematological oncology, vol. 31, no. 2, n.d., pp. 363–369. http://access.bl.uk/ark:/81055/vdc_100024532397.0x00001a